W.R. Berkley Corp’s Array Biopharma Inc ARRY Stock Holding History

W.R. Berkley Corp’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-77,048	Closed	-$3.57M	–	132
2019 Q2	$3.57M	Buy	+77,048	New	+$2.16M	0.61%	50

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

W.R. Berkley Corp's ARRY Position: Q3 2019 in Review

W.R. Berkley Corp sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 77,048 shares — an estimated $3.57M sold.

W.R. Berkley Corp first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $3.57M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

W.R. Berkley Corp reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
W.R. Berkley Corp sold 77,048 Array Biopharma Inc shares in Q3 2019, an estimated $3.57M.
W.R. Berkley Corp first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
W.R. Berkley Corp's Array Biopharma Inc position peaked at $3.57M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on W.R. Berkley Corp's 13F filing for Q3 2019, filed 14 Nov 2019.